Response from CGB, page-137

Hi yankie, I'm not here to put any downer. Have you ever heard of a company asking SHers and ASX to allow for over subscription of a CR? You have been told several times the CR was oversubscribed right? Sounds to me like a lot of investors are keen.
Why didn't the company try and raise enough for Medcan (& all their licenses) as well as enough money for the new MoU's (ROI, quicker rev) with new outfit?

All this talk of being a mammoth and a leader in the Australian industry and why not are they willing to try raise $10-12M for a suite of licenses and revenue MoU's.
Why wouldn't a BOD try to lock this in? in these early days of an industry with such a promising outlook?
I'm lost, E*L, BD mentioned the potential a hemp industry can have. BD, the longer you're insulated/sleeping, the longer investors will find amount place to invest hemp dollars.

BOD do your SHers a favour, pull your finger out and put them in the game.